Up a level |
Gafanov, R. and Powles, T.B. and Bedke, J. and Stus, V. and Wadde, T.S. and Nosov, D. and Pouliot, F. and Soulières, D. and Melichar, B. and Azevedo, S. and McDermott, R.S. and Vynnychenko, I. and Borchiellini, D. and Markus, M. and Bondarenko, I. and Lin, J. and Burgents, J. and Molife, L. R. and Rini (2021) Subsequent therapy following pembrolizumab + axitinib or sunitinib treatment for advanced renal cell carcinoma (RCC) in the phase III KEYNOTE-426 study. Annals of Oncology, 32 (5). p. 694. ISSN 0923-7534 (Print), 1569-8041 (Electronic)